X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs CIPLA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER CIPLA PFIZER/
CIPLA
 
P/E (TTM) x 31.0 44.8 69.3% View Chart
P/BV x 4.9 3.8 128.4% View Chart
Dividend Yield % 0.7 0.3 196.4%  

Financials

 PFIZER   CIPLA
EQUITY SHARE DATA
    PFIZER
Mar-16
CIPLA
Mar-17
PFIZER/
CIPLA
5-Yr Chart
Click to enlarge
High Rs2,724622 438.0%   
Low Rs1,611458 351.5%   
Sales per share (Unadj.) Rs440.9181.9 242.4%  
Earnings per share (Unadj.) Rs48.712.9 378.4%  
Cash flow per share (Unadj.) Rs75.829.3 258.5%  
Dividends per share (Unadj.) Rs15.002.00 750.0%  
Dividend yield (eoy) %0.70.4 186.9%  
Book value per share (Unadj.) Rs462.9155.7 297.4%  
Shares outstanding (eoy) m45.75804.51 5.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.93.0 165.5%   
Avg P/E ratio x44.542.0 106.1%  
P/CF ratio (eoy) x28.618.4 155.3%  
Price / Book Value ratio x4.73.5 135.0%  
Dividend payout %30.815.5 198.2%   
Avg Mkt Cap Rs m99,163434,516 22.8%   
No. of employees `0002.923.0 12.5%   
Total wages/salary Rs m2,75826,338 10.5%   
Avg. sales/employee Rs Th6,981.76,349.1 110.0%   
Avg. wages/employee Rs Th954.51,143.0 83.5%   
Avg. net profit/employee Rs Th771.1449.3 171.6%   
INCOME DATA
Net Sales Rs m20,170146,302 13.8%  
Other income Rs m8572,287 37.5%   
Total revenues Rs m21,028148,589 14.2%   
Gross profit Rs m4,31024,758 17.4%  
Depreciation Rs m1,23913,229 9.4%   
Interest Rs m51,594 0.3%   
Profit before tax Rs m3,92312,222 32.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7941,798 99.8%   
Profit after tax Rs m2,22810,354 21.5%  
Gross profit margin %21.416.9 126.3%  
Effective tax rate %45.714.7 311.0%   
Net profit margin %11.07.1 156.1%  
BALANCE SHEET DATA
Current assets Rs m16,29987,370 18.7%   
Current liabilities Rs m7,59433,081 23.0%   
Net working cap to sales %43.237.1 116.3%  
Current ratio x2.12.6 81.3%  
Inventory Days Days6587 75.1%  
Debtors Days Days2662 41.3%  
Net fixed assets Rs m8,622111,567 7.7%   
Share capital Rs m4581,609 28.4%   
"Free" reserves Rs m20,722123,645 16.8%   
Net worth Rs m21,180125,254 16.9%   
Long term debt Rs m2536,454 0.1%   
Total assets Rs m29,137209,532 13.9%  
Interest coverage x755.58.7 8,715.5%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.70.7 99.1%   
Return on assets %7.75.7 134.4%  
Return on equity %10.58.3 127.2%  
Return on capital %19.08.5 223.4%  
Exports to sales %0.134.2 0.2%   
Imports to sales %17.58.3 209.6%   
Exports (fob) Rs m1250,050 0.0%   
Imports (cif) Rs m3,52612,203 28.9%   
Fx inflow Rs m5251,066 0.1%   
Fx outflow Rs m14017,678 0.8%   
Net fx Rs m-8833,388 -0.3%   
CASH FLOW
From Operations Rs m3,43623,824 14.4%  
From Investments Rs m-6,991-13,127 53.3%  
From Financial Activity Rs m-619-13,239 4.7%  
Net Cashflow Rs m-4,174-2,478 168.4%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 63.9 20.8 307.2%  
Indian inst/Mut Fund % 7.5 12.2 61.5%  
FIIs % 4.9 23.7 20.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 23.7 26.2 90.5%  
Shareholders   85,207 161,166 52.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUVEN LIFE  SUN PHARMA  SANOFI INDIA  FDC LTD.  SHASUN PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 19, 2018 12:07 PM

TRACK PFIZER

PFIZER - STRIDES SHASUN LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS